B Montagnon

638 total citations
31 papers, 463 citations indexed

About

B Montagnon is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, B Montagnon has authored 31 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Epidemiology. Recurrent topics in B Montagnon's work include Viral Infections and Immunology Research (7 papers), Virus-based gene therapy research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). B Montagnon is often cited by papers focused on Viral Infections and Immunology Research (7 papers), Virus-based gene therapy research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). B Montagnon collaborates with scholars based in France and Finland. B Montagnon's co-authors include B Fanget, J. C. Vincent-Falquet, A Boué, Y. Pachéco, J.F. Saluzzo, M Perrin‐Fayolle, R Harf, Claude Chastang, Jean Bernard and Bernard Asselain and has published in prestigious journals such as The Lancet, Cancer and Clinical Infectious Diseases.

In The Last Decade

B Montagnon

28 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B Montagnon France	14	150	131	129	91	77	31	463
J. F. Boyd United Kingdom	14	103 0.7×	180 1.4×	110 0.9×	32 0.4×	44 0.6×	37	600
Oliver Greiner Switzerland	6	119 0.8×	148 1.1×	214 1.7×	45 0.5×	111 1.4×	10	527
Yuji Tanaka Japan	14	305 2.0×	283 2.2×	121 0.9×	30 0.3×	56 0.7×	28	698
Victor M. Areán United States	17	135 0.9×	104 0.8×	66 0.5×	43 0.5×	42 0.5×	38	714
Saskia Boisot United States	8	90 0.6×	48 0.4×	85 0.7×	94 1.0×	24 0.3×	9	438
P. A. Phillips Australia	11	97 0.6×	97 0.7×	48 0.4×	37 0.4×	103 1.3×	22	381
Silvia Resta United States	10	174 1.2×	327 2.5×	115 0.9×	25 0.3×	46 0.6×	16	710
E. M. Ayoub United States	9	106 0.7×	125 1.0×	93 0.7×	23 0.3×	29 0.4×	16	459
B. K. Aikat India	14	124 0.8×	123 0.9×	59 0.5×	16 0.2×	60 0.8×	48	524
Jorien Claes Belgium	12	261 1.7×	201 1.5×	153 1.2×	63 0.7×	26 0.3×	15	563

Countries citing papers authored by B Montagnon

Since Specialization

Citations

This map shows the geographic impact of B Montagnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Montagnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Montagnon more than expected).

Fields of papers citing papers by B Montagnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Montagnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Montagnon. The network helps show where B Montagnon may publish in the future.

Co-authorship network of co-authors of B Montagnon

This figure shows the co-authorship network connecting the top 25 collaborators of B Montagnon. A scholar is included among the top collaborators of B Montagnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Montagnon. B Montagnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Montagnon, B, J. C. Vincent-Falquet, & J.F. Saluzzo. (1999). Experience with vero cells at Pasteur Mérieux Connaught.. PubMed. 98. 137–40; discussion 167. 22 indexed citations

Mallet, L, F. Pelloquin, Pierre Caudrelier, et al.. (1997). Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on vero cells or on primary monkey kidney cells. Journal of Medical Virology. 52(1). 50–60. 13 indexed citations

Malvy, Denis, Jean‐Dominique Poveda, Monique Debruyne, et al.. (1992). Laser Immunonephelometry Reference Intervals for Eight Serum Proteins in Healthy Children. Clinical Chemistry. 38(3). 394–399. 16 indexed citations

Malvy, Denis, Jean‐Dominique Poveda, Monique Debruyne, et al.. (1992). Laser immunonephelometry reference intervals for eight serum proteins in healthy children.. PubMed. 38(3). 394–9. 15 indexed citations

Roivainen, Merja, et al.. (1990). Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice. Journal of Virology. 64(2). 559–562. 18 indexed citations

Roumiantzeff, M, et al.. (1985). Rabies vaccines produced in cell culture. Annales de l Institut Pasteur Virologie. 136(4). 413–424. 6 indexed citations

Montagnon, B, et al.. (1981). The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.. PubMed. 47. 55–64. 65 indexed citations

Perrin‐Fayolle, M, et al.. (1981). Angiotensin converting enzyme in bronchoalveolar lavage fluid in pulmonary sarcoidosis.. Thorax. 36(10). 790–792. 20 indexed citations

Montagnon, B, et al.. (1980). Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.. PubMed. 46. 197–202. 5 indexed citations

10.

Jl, Harousseau, et al.. (1980). [Acute myeloblastic leukaemia in the course of non-Hodgkin's lymphoma (author's transl)].. PubMed. 9(46). 3513–6. 1 indexed citations

11.

Montagnon, B, et al.. (1980). Contribution to the control of inactivated human influenza vaccines with the single radial diffusion method (SRD): Routine check, industrial super vision and vaccine standardisation. Comparative Immunology Microbiology and Infectious Diseases. 3(1-2). 207–218. 2 indexed citations

12.

Montagnon, B, et al.. (1980). Chemotherapy–radiotherapy association in Hodgkin's Disease, clinical stages IA, II2A: Results of a prospective clinical trial with 166 patients. Cancer. 46(10). 2126–2130. 35 indexed citations

13.

Perrin‐Fayolle, M, Arjan Bel, R Harf, et al.. (1980). [Asthma and gastro-esophageal reflux. Results of a survey over 150 cases (author's transl)].. PubMed. 36(4). 225–30. 25 indexed citations

14.

Falquet, Jacques, et al.. (1978). Production of inactivated rabies vaccine for human use on WI38 diploid cells. Results of potency tests. Stability of the vaccine in liquid and freeze-dried forms.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 40. 17–24. 5 indexed citations

15.

Tayot, J, et al.. (1973). Etude de vaccins influenza hautement purifiés. Journal of Biological Standardization. 1(4). 357–367. 2 indexed citations

16.

Boué, A, et al.. (1972). REINFECTION WITH RUBELLA IN PREGNANT WOMEN. Obstetrical & Gynecological Survey. 27(1). 18–19. 1 indexed citations

17.

Boué, A, et al.. (1971). REINFECTION WITH RUBELLA IN PREGNANT WOMEN. The Lancet. 297(7712). 1251–1253. 45 indexed citations

18.

Montagnon, B, et al.. (1970). Severe Illness in Children Exposed to Natural Measles after Prior Vaccination against the Disease: A Report of Six Cases. Scandinavian Journal of Infectious Diseases. 2(3). 157–160. 15 indexed citations

19.

Bernard, Julie, et al.. (1962). [Immunological study of combined antidiphtheritic, antitetanic, antityphoparatyphoid and antipoliomyelitic vaccinaction].. PubMed. 26. 699–725. 3 indexed citations

20.

Kirn, A., et al.. (1961). [Lytic properties of the serum. IV. Interference of antipoliomyelitic vaccine on the increase of obsistin induced in the monkey by antityphoparatyphoid A and B vaccination].. PubMed. 100. 613–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact